Ralph Zellweger
Impact in
- Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 13
- CRISPR and Genetic Engineering 6
- Cancer therapeutics and mechanisms 4
- Genomics and Chromatin Dynamics 2
- Oncology 5
- PARP inhibition in cancer therapy 4
- Cancer-related Molecular Pathways 1
- Co-authors
- Massimo Lopes (13 shared papers)Matteo Berti (4 shared papers)Karun Mutreja (4 shared papers)Raquel Herrador (4 shared papers)Alessandro Vindigni (2 shared papers)Jonas Schmid (2 shared papers)Damian Dalcher (1 shared paper)Pavel Janščák (3 shared papers)
- Journals
- Cell Reports (3 papers)Molecular Cell (2 papers)Nature Communications (2 papers)The Journal of Cell Biology (2 papers)EMBO Reports (1 paper)
- Partner nations
- SwitzerlandUnited StatesNetherlands
In The Last Decade
Ralph Zellweger
13 papers receiving 2.0k citations
Ralph Zellweger's Hit Papers
Peers
Comparison fields: 5 of 64
- Molecular Biology 1.9k
- Oncology 649
- Cancer Research 259
- Cell Biology 258
- Genetics 211
Countries citing papers authored by Ralph Zellweger
This map shows the geographic impact of Ralph Zellweger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Zellweger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Zellweger more than expected).
Fields of papers citing papers by Ralph Zellweger
This network shows the impact of papers produced by Ralph Zellweger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Zellweger. The network helps show where Ralph Zellweger may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralph Zellweger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells Hit paper breakdown → | 2015 | 532 |
| 2 | 2017 | 289 | |
| 3 | 2015 | 282 | |
| 4 | 2017 | 191 | |
| 5 | 2016 | 144 | |
| 6 | 2019 | 117 | |
| 7 | 2018 | 101 | |
| 8 | 2015 | 91 | |
| 9 | 2013 | 68 | |
| 10 | 2016 | 58 | |
| 11 | 2016 | 46 | |
| 12 | 2017 | 34 | |
| 13 | 2018 | 21 |
About Ralph Zellweger
Ralph Zellweger is a scholar working on Molecular Biology, Oncology, Cancer Research, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 13 papers that have together received 2.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (13 papers), CRISPR and Genetic Engineering (6 papers), Cancer therapeutics and mechanisms (4 papers), PARP inhibition in cancer therapy (4 papers), Genomics and Chromatin Dynamics (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), HIV/AIDS drug development and treatment (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Molecular Biology (1.9k citations), Oncology (649 citations), Cancer Research (259 citations), Cell Biology (258 citations) and Genetics (211 citations). Ralph Zellweger has collaborated with scholars based in Switzerland, United States and Netherlands. Frequent co-authors include Massimo Lopes, Matteo Berti, Karun Mutreja, Raquel Herrador, Alessandro Vindigni, Jonas Schmid, Damian Dalcher, Pavel Janščák, Sebastian Ursich and Nagaraja Chappidi. Their work appears in journals such as Cell Reports, Molecular Cell, Nature Communications, The Journal of Cell Biology and EMBO Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.